Sana Biotechnology, Inc. (SANA) — Stock Score Summary

Sana Biotechnology, Inc. (SANA) has a MoatMap StockRank of 3/100 based on Quality (22/100), Value (34/100), and Momentum (20/100) factor scores. The current signal is STRONG SELL. Sana Biotechnology is a pre-revenue cell and gene therapy developer that is highly speculative with a long path to commercialization, failing our quality and cash flow requirements.

Sana Biotechnology, Inc. is a clinical-stage biotechnology company focused on creating and delivering engineered cells as medicines for a range of challenging diseases. The company's competitive moat lies in its innovative gene and cell engineering platforms, aiming to develop both *in vivo* and *ex vivo* cell therapy approaches. Sana is a high-growth potential player in the cutting-edge field of cellular and gene therapies, targeting unmet medical needs.

Key Financial Metrics

Price$2.67
Market Cap$871M
P/E (Forward)-5.50
Price/Book4.91
Return on Equity-147.4%
Return on Invested Capital-60.8%
Debt/Equity69.30
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-30M

Sana Biotechnology, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Sana Biotechnology, Inc.’s (SANA) StockRank?
MoatMap’s StockRank for Sana Biotechnology, Inc. (SANA) is 3/100, with a Strong Sell signal. It is a composite of Quality (22), Value (34), and Momentum (20) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sana Biotechnology, Inc. have an economic moat?
Sana Biotechnology, Inc. (SANA) has a Quality factor score of 22/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sana Biotechnology, Inc. a buy, hold, or sell?
MoatMap’s current signal for Sana Biotechnology, Inc. (SANA) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sana Biotechnology, Inc. in?
Sana Biotechnology, Inc. (SANA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSANA deep dive reportAI ChampionsHow we score stocksSense-check another stock